Key points are not available for this paper at this time.
Design
Review
Highlights expanding AF burden in aging populations; leaves open optimal prevention strategies.
trial fibrillation (AF) is the most common cardiac arrhythmia and effects nearly 1% of the population.Its prevalence increases with increasing age; it is relatively infrequent in those under 40 years old, but occurs in up to 5% of those over 80 years of age.
No takes yet. Share an insight, caveat, or question.
Johan Waktare (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: